Professor Tang is a senior epidemiologist with a long standing interest in evidence-based healthcare, clinical evaluation of traditional Chinese medicine, systematic reviews and prevention of cardiovascular diseases, says The BMJ.
After qualifying as a public health doctor at Peking University, Professor Tang went on to obtain an MSc in epidemiology at the London School of Hygiene and Tropical Medicine and a PhD in Clinical Epidemiology at the University of London, and received post-doctoral training in the University of Oxford.
He is currently Director for Clinical Research at Guangzhou Women and Children’s Medical Centre (a cluster of hospitals) of Guangzhou Medical University.
He was formerly Head of Epidemiology and Associate Director of School of Public Health and Primary Care of the Chinese University of Hong Kong and the Hong Kong Cochrane Branch of the Cochrane Collaboration and is the Director for Peking University EBM Centre.
Among his honorary positions, Professor Tang serves as an editorial board member for The BMJ’s Chinese Edition and The Chinese Medical Journal English edition. He co-authored Evidence-Based Decision Making in Healthcare with Professor Sir Muir Gray of the University of Oxford and was co-editor of the Chinese version of BMJ Clinical Evidence.
Welcoming the appointment, Dr Fiona Godlee, The BMJ’s Editor in Chief said: “Professor Tang brings with him a wealth of knowledge and experience and will be invaluable in building on the journal’s global success and helping us to serve readers and authors in China and around the world.”
Professor Tang said: “The BMJ has a reputation for publishing the highest standards of scientific exchange and medical education. I hope to build on this success and continue to develop the academic credibility, educational profile, and strong international reputation of the journal in China.”
